605 related articles for article (PubMed ID: 27130858)
1. Investigation of peanut oral immunotherapy with CpG/peanut nanoparticles in a murine model of peanut allergy.
Srivastava KD; Siefert A; Fahmy TM; Caplan MJ; Li XM; Sampson HA
J Allergy Clin Immunol; 2016 Aug; 138(2):536-543.e4. PubMed ID: 27130858
[TBL] [Abstract][Full Text] [Related]
2. Engineered recombinant peanut protein and heat-killed Listeria monocytogenes coadministration protects against peanut-induced anaphylaxis in a murine model.
Li XM; Srivastava K; Huleatt JW; Bottomly K; Burks AW; Sampson HA
J Immunol; 2003 Mar; 170(6):3289-95. PubMed ID: 12626588
[TBL] [Abstract][Full Text] [Related]
3. Maternal allergy increases susceptibility to offspring allergy in association with TH2-biased epigenetic alterations in a mouse model of peanut allergy.
Song Y; Liu C; Hui Y; Srivastava K; Zhou Z; Chen J; Miller RL; Finkelman FD; Li XM
J Allergy Clin Immunol; 2014 Dec; 134(6):1339-1345.e7. PubMed ID: 25441650
[TBL] [Abstract][Full Text] [Related]
4. Peanut- and cow's milk-specific IgE, Th2 cells and local anaphylactic reaction are induced in Balb/c mice orally sensitized with cholera toxin.
Adel-Patient K; Bernard H; Ah-Leung S; Créminon C; Wal JM
Allergy; 2005 May; 60(5):658-64. PubMed ID: 15813812
[TBL] [Abstract][Full Text] [Related]
5. Food Allergy Herbal Formula-2 silences peanut-induced anaphylaxis for a prolonged posttreatment period via IFN-gamma-producing CD8+ T cells.
Srivastava KD; Qu C; Zhang T; Goldfarb J; Sampson HA; Li XM
J Allergy Clin Immunol; 2009 Feb; 123(2):443-51. PubMed ID: 19203662
[TBL] [Abstract][Full Text] [Related]
6. A Mouse Model of Peanut Allergy Induced by Sensitization Through the Gastrointestinal Tract.
Orgel K; Kulis M
Methods Mol Biol; 2018; 1799():39-47. PubMed ID: 29956142
[TBL] [Abstract][Full Text] [Related]
7. Anti-hIgE gene therapy of peanut-induced anaphylaxis in a humanized murine model of peanut allergy.
Pagovich OE; Wang B; Chiuchiolo MJ; Kaminsky SM; Sondhi D; Jose CL; Price CC; Brooks SF; Mezey JG; Crystal RG
J Allergy Clin Immunol; 2016 Dec; 138(6):1652-1662.e7. PubMed ID: 27372563
[TBL] [Abstract][Full Text] [Related]
8. The Chinese herbal medicine formula FAHF-2 completely blocks anaphylactic reactions in a murine model of peanut allergy.
Srivastava KD; Kattan JD; Zou ZM; Li JH; Zhang L; Wallenstein S; Goldfarb J; Sampson HA; Li XM
J Allergy Clin Immunol; 2005 Jan; 115(1):171-8. PubMed ID: 15637565
[TBL] [Abstract][Full Text] [Related]
9. Mixed antibody and T cell responses to peanut and the peanut allergens Ara h 1, Ara h 2, Ara h 3 and Ara h 6 in an oral sensitization model.
van Wijk F; Hartgring S; Koppelman SJ; Pieters R; Knippels LM
Clin Exp Allergy; 2004 Sep; 34(9):1422-8. PubMed ID: 15347376
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic effects of a fermented soy product on peanut hypersensitivity is associated with modulation of T-helper type 1 and T-helper type 2 responses.
Zhang T; Pan W; Takebe M; Schofield B; Sampson H; Li XM
Clin Exp Allergy; 2008 Nov; 38(11):1808-18. PubMed ID: 18705693
[TBL] [Abstract][Full Text] [Related]
11. Type B CpG oligodeoxynucleotides induce Th1 responses to peanut antigens: modulation of sensitization and utility in a truncated immunotherapy regimen in mice.
Kulis M; Gorentla B; Burks AW; Zhong XP
Mol Nutr Food Res; 2013 May; 57(5):906-15. PubMed ID: 23386314
[TBL] [Abstract][Full Text] [Related]
12. Oral immunotherapy using polymeric nanoparticles loaded with peanut proteins in a murine model of fatal anaphylaxis.
Gamazo C; García-Azpíroz M; Souza Rebouças J; Gastaminza G; Ferrer M; Irache JM
Immunotherapy; 2017 Nov; 9(15):1205-1217. PubMed ID: 29130802
[TBL] [Abstract][Full Text] [Related]
13. Analysis of cytokine production by peanut-reactive T cells identifies residual Th2 effectors in highly allergic children who received peanut oral immunotherapy.
Wisniewski JA; Commins SP; Agrawal R; Hulse KE; Yu MD; Cronin J; Heymann PW; Pomes A; Platts-Mills TA; Workman L; Woodfolk JA
Clin Exp Allergy; 2015 Jul; 45(7):1201-13. PubMed ID: 25823600
[TBL] [Abstract][Full Text] [Related]
14. A randomized, double-blind, placebo-controlled pilot study of sublingual versus oral immunotherapy for the treatment of peanut allergy.
Narisety SD; Frischmeyer-Guerrerio PA; Keet CA; Gorelik M; Schroeder J; Hamilton RG; Wood RA
J Allergy Clin Immunol; 2015 May; 135(5):1275-82.e1-6. PubMed ID: 25528358
[TBL] [Abstract][Full Text] [Related]
15. Oral sensitization to peanut is highly enhanced by application of peanut extracts to intact skin, but is prevented when CpG and cholera toxin are added.
Adel-Patient K; Ah-Leung S; Bernard H; Durieux-Alexandrenne C; Créminon C; Wal JM
Int Arch Allergy Immunol; 2007; 143(1):10-20. PubMed ID: 17191005
[TBL] [Abstract][Full Text] [Related]
16. Microneedles coated with peanut allergen enable desensitization of peanut sensitized mice.
Shakya AK; Ingrole RSJ; Joshi G; Uddin MJ; Anvari S; Davis CM; Gill HS
J Control Release; 2019 Nov; 314():38-47. PubMed ID: 31626861
[TBL] [Abstract][Full Text] [Related]
17. Current Trend in Immunotherapy for Peanut Allergy.
Joo Chan C; Richardo T; Lim RLH
Int Rev Immunol; 2018; 37(6):279-290. PubMed ID: 30638084
[TBL] [Abstract][Full Text] [Related]
18. B-FAHF-2 plus oral immunotherapy (OIT) is safer and more effective than OIT alone in a murine model of concurrent peanut/tree nut allergy.
Srivastava KD; Song Y; Yang N; Liu C; Goldberg IE; Nowak-Węgrzyn A; Sampson HA; Li XM
Clin Exp Allergy; 2017 Aug; 47(8):1038-1049. PubMed ID: 28397379
[TBL] [Abstract][Full Text] [Related]
19. Mouse strain differences in response to oral immunotherapy for peanut allergy.
Wagenaar L; Bol-Schoenmakers MWHC; Giustarini G; Garssen J; Smit JJ; Pieters RHH
Immun Inflamm Dis; 2019 Mar; 7(1):41-51. PubMed ID: 30838819
[TBL] [Abstract][Full Text] [Related]
20. Peanut gastrointestinal delivery oral immunotherapy in adolescents: Results of the build-up phase of a randomized, double-blind, placebo-controlled trial (PITA study).
Fauquert JL; Michaud E; Pereira B; Bernard L; Gourdon-Dubois N; Rouzaire PO; Rochette E; Merlin E; Evrard B;
Clin Exp Allergy; 2018 Jul; 48(7):862-874. PubMed ID: 29665158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
